NDC80 status pinpoints mitotic kinase inhibitors as emerging therapeutic options in clear cell renal cell carcinoma

Authors:

Abstract
No abstract available
All Related Versions
Funding Information
  • National Natural Science Foundation of China (81773771)
  • Fujian Provincial Department of Science and Technology (2018J01053, 2021Y0002)
  • Xiamen University
  • Fundamental Research Funds for the Central Universities (20720220053)
  • Fundamental Research Funds for the Central Universities
  • Science and Technology Projects of Fujian Province

This publication has 50 references indexed in Scilit: